Semaglutide's Amino Acid Sequence and What It Tells You About the Medicine

The decision behind the design: why scientists changed the natural GLP-1 sequence

The GLP-1 hormone your gut releases after a meal does exactly what semaglutide does, briefly. Native GLP-1 is broken down by an enzyme called DPP-4 within two to three minutes of release. That speed is fine for blood-sugar signalling after lunch; it is useless as a medicine you want to take once a week.

Novo Nordisk's chemists addressed this by altering three positions in the 31-amino-acid chain. The substitution at position 8 (replacing alanine with alpha-aminoisobutyric acid) blocks the site where DPP-4 cleaves the molecule. The C18 fatty diacid chain grafted at position 26, via a short linker, does two things: it lets semaglutide bind to albumin (the blood's main carrier protein) and it makes the molecule slightly more resistant to kidney filtration. Together, these changes extend the half-life to roughly seven days, matching a once-weekly injection schedule. You can read more about how the medicine is used over time on our semaglutide dosing frequency page.

The rest of the sequence is largely conserved from human GLP-1, which matters clinically: it means semaglutide activates the same receptor with the same biological logic (appetite reduction, slower gastric emptying, improved insulin signalling) without introducing an entirely foreign molecular shape. The full semaglutide overview covers how those effects translate into the treatment itself.

What the sequence means for oral versus injectable semaglutide

The same 31-amino-acid chain underlies both the injection (Wegovy) and the oral tablet (also branded Wegovy, approved by the MHRA on 11 June 2026 as the first oral GLP-1 medicine licensed in the UK for weight management). The structural challenge for the oral route is not the sequence itself but getting that sequence through the stomach intact.

Stomach acid and digestive enzymes are designed to break peptides apart. Semaglutide's modifications help, but they are not enough on their own. The tablet co-formulates semaglutide with SNAC (sodium salcaprozate) an absorption enhancer that locally raises gastric pH around the tablet and helps the molecule cross the stomach lining before it is digested. Our page on semaglutide and stomach acid explains this in more practical terms.

The bioavailability of oral semaglutide is considerably lower than the injection (around 1% versus near-complete subcutaneous absorption), which is why the oral maintenance dose climbs to 25 mg compared with 2.4 mg weekly for the injection. The amino acid sequence is identical; the delivery system does the heavy lifting. Both forms are licensed medicines that require a prescriber's assessment. Details on the oral option are on our Wegovy page.

Why the exact sequence matters for safety, and what that means if you are considering alternatives

A question our prescribers hear regularly is whether compounded or alternative semaglutide products carry the same risks and the same results as the licensed medicine. The amino acid sequence is one part of the answer.

Pharmaceutical-grade semaglutide is manufactured to tightly controlled specifications: the sequence, the folding, the fatty-acid chain attachment, and the absence of impurities are all verified batch by batch. Compounded or counterfeit products may share the same target sequence on paper but differ in purity, concentration and structural integrity. The MHRA has warned about fake weight-loss pens sold online, some found to contain entirely different active substances. You can report suspect products through the Yellow Card scheme.

There is a separate commercial brand, Bioamino Labs semaglutide, that appears in searches alongside licensed medicines, our page clarifies its status. For a look at what the clinical trials established about results in the licensed form, the NHS semaglutide medicines page is a reliable starting point. Those trials used precisely characterised, pharmaceutical-grade material; that is what the efficacy figures reflect.

Cost is worth considering too, and context helps: our Wegovy cost breakdown sets out what a legitimate prescription actually includes beyond the medicine itself. One thing worth knowing: the pen you receive from a regulated pharmacy arrives in plain, unbranded packaging with DPD tracking, so you can follow it to your door, and what's inside has been dispensed through the licensed UK supply chain.

If any of this raises questions about whether Wegovy or tirzepatide might suit your situation, our prescribers can discuss your history properly. Explore your options on our weight-loss treatments page and start a free consultation when you are ready.